Haploinsufficient TNAP Mice Display Decreased Extracellular ATP Levels and Expression of Pannexin-1 Channels
Hypophosphatasia (HPP) is a rare heritable metabolic bone disease caused by hypomorphic mutations in the ALPL (in human) or Akp2 (in mouse) gene, encoding the tissue-nonspecific alkaline phosphatase (TNAP) enzyme. In addition to skeletal and dental malformations, severe forms of HPP are also charact...
Main Authors: | Álvaro Sebastián-Serrano, Laura de Diego-García, David C. Henshall, Tobías Engel, Miguel Díaz-Hernández |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00170/full |
Similar Items
-
TNAP as a New Player in Chronic Inflammatory Conditions and Metabolism
by: Stephanie Graser, et al.
Published: (2021-01-01) -
TNAP and P2X7R: New Plasma Biomarkers for Alzheimer’s Disease
by: Paloma Aivar, et al.
Published: (2023-06-01) -
Tissue-Nonspecific Alkaline Phosphatase—A Gatekeeper of Physiological Conditions in Health and a Modulator of Biological Environments in Disease
by: Daniel Liedtke, et al.
Published: (2020-12-01) -
Tissue-nonspecific Alkaline Phosphatase Regulates Purinergic Transmission in the Central Nervous System During Development and Disease
by: Álvaro Sebastián-Serrano, et al.
Published: (2015-01-01) -
The Pannexins: Past and Present
by: Steven eBond, et al.
Published: (2014-02-01)